K992136

Substantially Equivalent

BAYER ADVIA INTEGRATED MODULAR SYSTEM (IMS)

Applicant: Bayer Corp.
Product code: CIT
Advisory panel: Clinical Chemistry
Date received: 1999-06-24
Decision date: 1999-11-09
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Tarrytown, NY, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.